UEG (467 HK) Company Update Summary
Core Content Overview
UEG (467 HK) reported a $30%$ YoY increase in net profit in 2022, reaching HK$2.6bn. Excluding impairment losses and depreciation, the core net profit was HK$3.43bn, aligning closely with the forecast of HK$3.5bn. The company generated HK$7.8bn in operating cash flow, a $83%$ increase YoY, which is 3 times the net profit. The firm has not proposed dividends, instead prioritizing capital expenditures (US$0.99–1.05bn in 2023E) to boost production and repay debts in the context of rising interest rates.
Main Points and Key Information
2022 Performance Highlights
- Revenue: Increased by $55%$ YoY to US$2.5bn, driven by a $44%$ rise in realized oil & gas prices and a $7.7%$ increase in sales volume.
- Net Revenue: Grew $45%$ YoY to HK$10.7bn after stripping out government royalties and levies.
- Production: Achieved an average daily working interest production of 100k boed, up $7.7%$ YoY.
- Iraq Block 9: Continued to be the fastest-growing asset, with a $33%$ YoY increase in production to 34.7k boed.
- Asset Performance: Pakistan and Egypt saw production declines of $2.6%$ and $1.6%$ YoY, respectively, while Iraq Siba showed a slight increase.
Cost and Depreciation
- Lifting Cost: Reduced by ~$2%$ YoY to US$4.1/boe, due to a $9%$ drop in unit costs in the Middle East & North Africa (MENA) region, offsetting a $5%$ increase in Pakistan.
- Depreciation: Rose $41%$ YoY to HK$4bn, impacting net profit.
Financial Health
- Balance Sheet: Improved significantly, with the net debt to equity ratio dropping to 1.4% from 10% in 2021.
- Operating Cash Flow: Generated HK$7.8bn, sufficient to cover investment spending and repay HK$1.2bn in bank loans.
- Earnings Forecast: Trimmed by 9.8% and 11.6% for 2023E and 2024E, respectively, due to lower volume, oil & gas prices, and higher depreciation.
- Target Price: Revised down to HK$1.60 from HK$1.77, with a P/E ratio of 10x.
Earnings and Revenue Trends
| Year |
Revenue (HK$ mn) |
YoY Growth (%) |
Net Income (HK$ mn) |
YoY Growth (%) |
| FY21A |
7,437 |
19.9 |
2,001 |
131.6 |
| FY22A |
10,754 |
44.6 |
2,601 |
30.3 |
| FY23E |
11,327 |
5.3 |
4,199 |
61.4 |
| FY24E |
12,788 |
12.9 |
4,373 |
4.1 |
| FY25E |
14,865 |
16.2 |
4,853 |
11.0 |
Key Ratios and Metrics
| Metric |
FY21A |
FY22A |
FY23E |
FY24E |
FY25E |
| Operating Margin (%) |
37.1 |
33.4 |
46.0 |
42.0 |
39.6 |
| Pre-Tax Margin (%) |
32.7 |
28.1 |
42.9 |
39.5 |
37.7 |
| Net Margin (%) |
26.9 |
24.2 |
37.1 |
34.2 |
32.6 |
| ROE (%) |
14.1 |
16.5 |
20.9 |
18.5 |
17.6 |
| Net Debt/Equity (%) |
10.0 |
1.4 |
Net Cash |
Net Cash |
Net Cash |
Investment Recommendation
- Rating: BUY (Maintain)
- Target Price: HK$1.60 (Down from HK$1.77)
- Upside/Downside: 72%
Risk Factors
- Further decline in crude and gas prices.
- Risk of impairment loss in Pakistan assets.
- Higher-than-expected capital expenditures.
Analyst Information
Stock Data
| Metric |
Value (HK$) |
| Market Cap |
24,450 mn |
| Average 3 mths t/o |
17.6 mn |
| 52w High/Low |
1.32 / 0.63 |
| Total Issued Shares |
26,290 mn |
Shareholding Structure
| Holder |
Percentage |
| Zhang Hong Wei |
66.44% |
| Free Float |
33.56% |
Share Performance
| Period |
Absolute (%) |
Relative (%) |
| 1-mth |
48.6 |
44.8 |
| 3-mth |
39.0 |
35.4 |
| 6-mth |
18.9 |
0.8 |
Financial Summary
Income Statement Highlights
- Operating Profit: Increased from FY21A to FY25E, with FY23E at HK$4,523mn.
- Net Profit: Rose to HK$4,853mn in FY25E, up from HK$2,001mn in FY21A.
Cash Flow Summary
- Operating Cash Flow: Increased significantly, reaching HK$10,955mn in FY25E.
- Capex: Expected to be US$7.6bn in FY23E, decreasing in subsequent years.
Balance Sheet Highlights
- Total Assets: Grew from HK$25,032mn in FY21A to HK$40,400mn in FY25E.
- Current Liabilities: Increased from HK$5,093mn to HK$9,621mn.
- Total Equity: Rose from HK$14,240mn to HK$27,636mn.
CMBIGM Ratings
- BUY: Potential return of over $15%$ over next 12 months.
- OUTPERFORM: Industry expected to outperform the relevant broad market benchmark.
Important Disclosures
- This report is not investment advice and should not be relied upon for making investment decisions.
- CMBIGM is not liable for any losses or damages arising from the use of the information.
- The report is intended solely for the use of the intended recipients and may not be reproduced or distributed without prior written consent.